[Federal Register Volume 73, Number 189 (Monday, September 29, 2008)]
[Notices]
[Pages 56613-56614]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-22875]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated March 19, 2008 and published in the Federal 
Register on March 28, 2008 (73 FR 16719), Alltech Associates Inc., 2051 
Waukegan Road, Deerfield, Illinois 60015, made application to the Drug 
Enforcement Administration (DEA) to be registered as

[[Page 56614]]

a bulk manufacturer of the basic classes of controlled substances 
listed in schedules I and II:

------------------------------------------------------------------------
                       Drug                               Schedule
------------------------------------------------------------------------
Methcathinone (1237)..............................  I
N-Ethylamphetamine (1475).........................  I
N,N-Dimethylamphetamine (1480)....................  I
4-Methylaminorex (cis isomer) (1590)..............  I
Alpha-ethyltryptamine (7249)......................  I
Lysergic acid diethylamide (7315).................  I
2,5-Dimethoxy-4-(n)-propylthiophenethylamine        I
 (7348).
Tetrahydrocannabinols (7370)......................  I
Mescaline (7381)..................................  I
4-Bromo-2,5-dimethoxyamphetamine (7391)...........  I
4-Bromo-2,5-dimethoxyphenethylamine (7392)........  I
4-Methyl-2,5-dimethoxyamphetamine (7395)..........  I
2,5-Dimethoxyamphetamine (7396)...................  I
2,5-Dimethoxy-4-ethylamphetamine (7399)...........  I
3,4-Methylenedioxyamphetamine (7400)..............  I
N-Hydroxy-3,4-methylenedioxyamphetamine (7402)....  I
3,4-Methylenedioxy-N-ethylamphetamine (7404)......  I
3,4-Methylenedioxymethamphetamine (MDMA) (7405)...  I
4-Methoxyamphetamine (7411).......................  I
Alpha-methyltryptamine (7432).....................  I
Bufotenine (7433).................................  I
Diethyltryptamine (7434)..........................  I
Dimethyltryptamine (7435).........................  I
Psilocybin (7437).................................  I
Psilocyn (7438)...................................  I
5-Methoxy-N,N-diisopropyltryptamine (7439)........  I
N-Ethyl-1-phenylcyclohexylamine (7455)............  I
1-(1-Phenylcyclohexyl)pyrrolidine (7458)..........  I
1-Phenylcyclohexylamine (7460)....................  I
1-[1-(2-Thienyl)cyclohexyl]piperidine (7470)......  I
Normorphine (9313)................................  I
Methamphetamine (1105)............................  II
Phencyclidine (7471)..............................  II
Phenylacetone (8501)..............................  II
1-Piperidinocyclohexanecarbonitrile (8603)........  II
Cocaine (9041)....................................  II
Codeine (9050)....................................  II
Dihydrocodeine (9120).............................  II
Dihydromorphine (9145)............................  II
Ecgonine (9180)...................................  II
Meperidine intermediate-B (9233)..................  II
Noroxymorphone (9668).............................  II
------------------------------------------------------------------------

    The company plans to manufacture high purity drug standards used 
for analytical applications only in clinical, toxicological, and 
forensic laboratories.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Alltech Associates, Inc. to manufacture the listed basic classes of 
controlled substances is consistent with the public interest at this 
time. DEA has investigated Alltech Associates Inc. to ensure that the 
company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 
21 CFR 1301.33, the above named company is granted registration as a 
bulk manufacturer of the basic classes of controlled substances listed.

     Dated: September 22, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E8-22875 Filed 9-26-08; 8:45 am]
BILLING CODE 4410-09-P